HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cardiovascular Diseases (Cardiovascular Disease)

Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM.
Also Known As:
Cardiovascular Disease; Adverse Cardiac Events; Cardiac Event; Cardiac Event, Adverse; Cardiac Events, Adverse; Disease, Cardiovascular; Event, Cardiac; Adverse Cardiac Event; Cardiac Events; Major Adverse Cardiac Events
Networked: 91362 relevant articles (3554 outcomes, 13223 trials/studies)

Relationship Network

Disease Context: Research Results

Related Diseases

1. Neoplasms (Cancer)
2. Hypertension (High Blood Pressure)
3. Type 2 Diabetes Mellitus (MODY)
4. Atherosclerosis
5. Heart Failure

Experts

1. Ridker, Paul M: 168 articles (01/2022 - 01/2002)
2. Jeong, Myung Ho: 163 articles (05/2022 - 09/2003)
3. Manson, JoAnn E: 158 articles (10/2022 - 01/2002)
4. Ballantyne, Christie M: 150 articles (11/2022 - 08/2002)
5. Budoff, Matthew J: 145 articles (10/2022 - 03/2002)
6. Serruys, Patrick W: 143 articles (01/2021 - 02/2002)
7. Stone, Gregg W: 142 articles (02/2022 - 05/2002)
8. Bhatt, Deepak L: 134 articles (11/2022 - 01/2002)
9. Mehran, Roxana: 134 articles (11/2022 - 05/2002)
10. Blaha, Michael J: 132 articles (10/2022 - 08/2008)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Cardiovascular Diseases:
1. Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
11/17/2020 - "The most relevant codes were "pile sorted" into 5 main topic domains: (1) SASEs vary in severity, duration, and time of onset; (2) communication practices by clinicians around statins and SASEs are variable and impacted by clinician time limitations and patient preconceived notions of SASEs; (3) although a "trial and error" approach to managing SASEs may be effective in allowing clinicians to keep patients with atherosclerotic cardiovascular disease on a statin, it can be frustrating for patients; (4) outside sources, such as the media, internet, social networks, and social circles, influence patients' perceptions and often impact the risk benefit discussion; and (5) a decision aid would be beneficial in facilitating clinician decision-making around SASEs and discussion of SASEs with the patients. "
06/01/2020 - "Although statins are highly effective for reducing cardiovascular disease events, prior studies demonstrate their significant underuse in the US population, including among those with known atherosclerotic disease. "
01/01/2022 - "Given the potential improvement in accuracy in predicting cardiovascular disease when reduction in levels of non-HDL-C is used as the primary target, these findings provide guidance on which statin types and intensities are most effective by reducing non-HDL-C in patients with diabetes. "
01/01/2021 - "The comparative analysis of the effect of several doses of statins against different intensities of physical exercise on arterial stiffness (a measure of cardiovascular risk) could shed light for clinicians on which method is most effective in preventing cardiovascular disease (CVD) and be used to inform shared decision-making between doctors and patients. "
05/01/2012 - "The use of statins has scaled up to become one of the most prescribed medicines in the world and have been very useful in the manegement of cardiovascular diseases and related mortality. "
2. LipidsIBA
3. AntioxidantsIBA
4. CholesterolIBA
5. Biomarkers (Surrogate Marker)IBA
6. Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
7. oxidized low density lipoproteinIBA
8. LDL CholesterolIBA
9. Estrogens (Estrogen)FDA Link
10. Glucose (Dextrose)FDA LinkGeneric

Therapies and Procedures

1. Therapeutics
2. Secondary Prevention
3. Cardiac Rehabilitation
4. Stents
5. Glycemic Control